secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001477932-24-005924
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab enters biogas sector in Malaysia via partnership with Protech Builders
--------------------------------------------------------------------------------

- MRNA Scientific (BGLC subsidiary) and Protech Builders signed a 3-year teaming agreement to develop biogas plants in Malaysia.
- Initial joint contribution of up to RM1,000,000 (~USD 235,000) for feasibility studies and project development.
- Projects will convert plantation wastewater into renewable energy; Protech holds G7 license for unlimited-scale construction.
- Protech has over 300 completed projects across Malaysia, including biogas and power transmission systems.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793224005924/0001477932-24-005924-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793224005924/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-005924

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer